About 12 million adults in the United States are affected by PTSD, impacting between 4% and 8% of the adult population—and up ...

FDA rejects Rexulti's approval for PTSD treatment, citing insufficient evidence of effectiveness in combination with sertraline. Otsuka and Lundbeck announced they are planning next steps.

The FDA has issued a CRL to Otsuka and Lundbeck regarding the sNDA for brexpiprazole in combination with sertraline for the treatment of adults with PTSD.

An experimental drug reverses PTSD-like symptoms in mice. The corresponding study was published in Signal Transduction and Targeted Therapy and may pave the way for a new treatment for PTSD. “This ...

No new PTSD drug approvals in the U.S. in nearly 25 years; large potential addressable market for SPC-15 worldwide SARASOTA, FL, July 07, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) ...

Generalized anxiety disorder affects 1 in 20 U.S. adults. Those with serious symptoms may isolate themselves to the point ...

Rikki Harris of TN Voices says the state should support efforts to mandate ibogaine to treat addiction and PTSD.

Researchers are discovering that post-traumatic stress disorder (PTSD) is a significant risk factor in developing dementia. Dementia is a memory problem that affects a person's ability to carry out ...

Being in the military means you may witness things or be involved in combat or missions that are life-threatening and horrible to deal with. There are accidents, training injuries, or difficult ...

PTSD affects about 12 million U.S. adults, with veterans hit especially hard – and many also grappling with alcohol use ...